CGON

CG Oncology, Inc.

Contracts

Total Value

Stock Metrics

18.0%

Short % Float

13.5d to cover · Moderate squeeze

1.1%

Inst % Float

10 holders · 2026-06-30

RTW Investments LP

Top Holder

9.6% of float

65.8M sh

Public Float

27/100

Dilution Score

Medium

107 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

27/100

MEDIUM

Inst: 1.14% · Top: RTW Investments LP

Biotech Analytics

Oncology

38.42

Squeeze risk: MODERATEBiotech Grade: D

Insider Buying0

Publications100

Dilution Risk27

Clinical Trials62

Short Interest50